<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Omer S</submitter><pubmed_abstract>SARS-CoV-2 is a causative agent for COVID-19 disease, initially reported from Wuhan, China. The infected patients experienced mild to severe symptoms, resulting in several fatalities due to a weak understanding of its pathogenesis, which is the same even to date. This cross-sectional study has been designed on 452 symptomatic mild-to-moderate and severe/critical patients to understand the epidemiology and clinical characteristics of COVID-19 patients with their comorbidities and response to treatment. The mean age of the studied patients was 58 ± 14.42 years, and the overall male to female ratio was 61.7 to 38.2%, respectively. In total, 27.3% of the patients had a history of exposure, and 11.9% had a travel history, while for 60% of patients, the source of infection was unknown. The most </pubmed_abstract><journal>Frontiers in cellular and infection microbiology</journal><pagination>800511</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9226825</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2-Infected Pakistani Patients.</pubmed_title><pmcid>PMC9226825</pmcid><pubmed_authors>Omer S</pubmed_authors><pubmed_authors>Akram J</pubmed_authors><pubmed_authors>Shahzad F</pubmed_authors><pubmed_authors>Afzal N</pubmed_authors><pubmed_authors>Gondal MF</pubmed_authors><pubmed_authors>Khan A</pubmed_authors><pubmed_authors>Tahir R</pubmed_authors><pubmed_authors>Jahan S</pubmed_authors><pubmed_authors>Faizan RM</pubmed_authors><pubmed_authors>Qaiser TA</pubmed_authors><pubmed_authors>Ayub S</pubmed_authors><pubmed_authors>Naveed MA</pubmed_authors><pubmed_authors>Usman M</pubmed_authors><pubmed_authors>Sarwar MB</pubmed_authors><pubmed_authors>Yasir M</pubmed_authors><pubmed_authors>Roman M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2-Infected Pakistani Patients.</name><description>SARS-CoV-2 is a causative agent for COVID-19 disease, initially reported from Wuhan, China. The infected patients experienced mild to severe symptoms, resulting in several fatalities due to a weak understanding of its pathogenesis, which is the same even to date. This cross-sectional study has been designed on 452 symptomatic mild-to-moderate and severe/critical patients to understand the epidemiology and clinical characteristics of COVID-19 patients with their comorbidities and response to treatment. The mean age of the studied patients was 58 ± 14.42 years, and the overall male to female ratio was 61.7 to 38.2%, respectively. In total, 27.3% of the patients had a history of exposure, and 11.9% had a travel history, while for 60% of patients, the source of infection was unknown. The most </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T08:47:37.082Z</modification><creation>2025-04-04T08:47:37.082Z</creation></dates><accession>S-EPMC9226825</accession><cross_references><pubmed>35755851</pubmed><doi>10.3389/fcimb.2022.800511</doi></cross_references></HashMap>